Daniel Moreno-Gonzalez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Journal: Journal of the American Heart Association

Published: February 12, 2026

Finerenone: Evidence for benefit in Early Stages of Cardiovascular-Kidney-Metabolic Syndrome.

Finerenone: Evidence for benefit in Early Stages of Cardiovascular-Kidney-Metabolic Syndrome.

Journal: Cardiorenal medicine

Published: July 04, 2025

Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation.

Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation.

Journal: The Journal of pathology

Published: May 08, 2024

Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation.

Interleukin-6 as a prognostic marker in acute kidney injury and its klotho-dependent regulation.

Journal: Nefrologia

Published: December 12, 2023

Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats.

Upregulation in Inflammation and Collagen Expression in Perirenal but Not in Mesenteric Adipose Tissue from Diabetic Munich Wistar Frömter Rats.

Journal: International journal of molecular sciences

Published: October 20, 2023

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.

Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 07, 2023

Angiotensin II type 2 receptor as a novel activator of brown adipose tissue in obesity.

Angiotensin II type 2 receptor as a novel activator of brown adipose tissue in obesity.

Journal: BioFactors (Oxford, England)

Published: April 10, 2023

Short-term dietary intervention improves endothelial dysfunction induced by high-fat feeding in mice through upregulation of the AMPK-CREB signaling pathway.

Short-term dietary intervention improves endothelial dysfunction induced by high-fat feeding in mice through upregulation of the AMPK-CREB signaling pathway.

Journal: Acta physiologica (Oxford, England)

Published: April 01, 2023

Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease.

Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease.

Journal: International journal of molecular sciences

Published: October 04, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026